Anti-HLA I antibodies induce VEGF production by endothelial cells, which increases proliferation and paracellular permeability

International Journal of Biochemistry and Cell Biology

Volumn 41, Issue 12, 2009, Pages 2422-2430

  Bieri, Michael ^a   Oroszlan, Melinda ^a   Farkas, Anikò ^a   Ligeti, Nathalie ^a   Bieri, Jürg ^b   Mohacsi, Paul ^a  

^a BERN UNIVERSITY HOSPITAL   (Switzerland)

^b Lindenhofspital   (Switzerland)

Author keywords

Adhesion molecule; Antibodies; Endothelial cells; MHC; Transplantation

Indexed keywords

HLA 1 ANTIBODY; HLA ANTIBODY; PROTEIN KINASE P60; UNCLASSIFIED DRUG; VASCULAR ENDOTHELIAL CADHERIN; VASCULOTROPIN; VASCULOTROPIN RECEPTOR 2;

ARTICLE; AUTOCRINE EFFECT; CELL ADHESION; CELL ISOLATION; CELL JUNCTION; CELL MEMBRANE PERMEABILITY; CELL PROLIFERATION; CELL STIMULATION; COMPLEMENT SYSTEM; CONTROLLED STUDY; EDEMA; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; NUCLEOTIDE SEQUENCE; PROTEIN CROSS LINKING; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN SYNTHESIS; TRANSACTIVATION; UMBILICAL VEIN;

ANTIBODIES; CADHERINS; CELL MEMBRANE PERMEABILITY; CELL PROLIFERATION; CELLS, CULTURED; EDEMA; ENDOTHELIAL CELLS; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; IMMUNIZATION; PHOSPHORYLATION; SIGNAL TRANSDUCTION; TIGHT JUNCTIONS; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2;

EID: 70350348950     PISSN: 13572725     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biocel.2009.06.009     Document Type: Article

References (30)

1. Ali N., Yoshizumi M., Yano S., Sone S., Ohnishi H., Ishizawa K., et al. The novel Src kinase inhibitor M475271 inhibits VEGF-induced vascular endothelial-cadherin and beta-catenin phosphorylation but increases their association. J Pharmacol Sci 102 (2006) 112-120
2. Bieri M., Oroszlan M., Zuppinger C., and Mohacsi P.J. Biosynthesis and expression of VE-cadherin is regulated by the PI3K/mTOR signaling pathway. Mol Immunol 46 (2009) 866-872
3. Bocci G., Fasciani A., Danesi R., Viacava P., Genazzani A.R., and Del Tacca M. In-vitro evidence of autocrine secretion of vascular endothelial growth factor by endothelial cells from human placental blood vessels. Mol Hum Reprod 7 (2001) 771-777
4. Dragun D., Muller D.N., Brasen J.H., Fritsche L., Nieminen-Kelha M., Dechend R., et al. Angiotensin II type 1-receptor activating antibodies in renal-allograft rejection. N Engl J Med 352 (2005) 558-569
5. Friedl J., Puhlmann M., Bartlett D.L., Libutti S.K., Turner E.N., Gnant M.F., et al. Induction of permeability across endothelial cell monolayers by tumor necrosis factor (TNF) occurs via a tissue factor-dependent mechanism: relationship between the procoagulant and permeability effects of TNF. Blood 100 (2002) 1334-1339
6. Gavard J., and Gutkind J.S. VEGF controls endothelial-cell permeability by promoting the beta-arrestin-dependent endocytosis of VE-cadherin. Nat Cell Biol 8 (2006) 1223-1234
7. Ha C.H., Bennett A.M., and Jin Z.G. A novel role of vascular endothelial cadherin in modulating c-Src activation and downstream signaling of vascular endothelial growth factor. J Biol Chem (2008)
8. Jaffe E.A., Nachman R.L., Becker C.G., and Minick C.R. Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria. J Clin Invest 52 (1973) 2745-2756
9. Jin Y.P., Jindra P.T., Gong K.W., Lepin E.J., and Reed E.F. Anti-HLA class I antibodies activate endothelial cells and promote chronic rejection. Transplantation 79 (2005) S19-21
10. Jin Y.P., Korin Y., Zhang X., Jindra P.T., Rozengurt E., and Reed E.F. RNA interference elucidates the role of focal adhesion kinase in HLA class I-mediated focal adhesion complex formation and proliferation in human endothelial cells. J Immunol 178 (2007) 7911-7922
11. Jin Y.P., Singh R.P., Du Z.Y., Rajasekaran A.K., Rozengurt E., and Reed E.F. Ligation of HLA class I molecules on endothelial cells induces phosphorylation of Src, paxillin, and focal adhesion kinase in an actin-dependent manner. J Immunol 168 (2002) 5415-5423
12. Jindra P.T., Zhang X., Mulder A., Claas F., Veale J., Jin Y.P., et al. Anti-HLA antibodies can induce endothelial cell survival or proliferation depending on their concentration. Transplantation 82 (2006) S33-35
13. Kobayashi T., Yokoyama I., Morozumi K., Nagasaka T., Hayashi S., Uchida K., et al. Comparative study of the efficacy of removal of anti-ABO and anti-gal antibodies by double filtration plasmapheresis. Xenotransplantation 7 (2000) 101-108
14. Kumlien G., Ullstrom L., Losvall A., Persson L.G., and Tyden G. Clinical experience with a new apheresis filter that specifically depletes ABO blood group antibodies. Transfusion 46 (2006) 1568-1575
15. McKenna R.M., Takemoto S.K., and Terasaki P.I. Anti-HLA antibodies after solid organ transplantation. Transplantation 69 (2000) 319-326
16. Mihaylova A., Baltadjieva D., Boneva P., Ivanova M., Penkova K., Marinova D., et al. Clinical relevance of anti-HLA antibodies detected by flow-cytometry bead-based assays-single-center experience. Hum Immunol 67 (2006) 787-794
17. Mizutani K., Terasaki P., Rosen A., Esquenazi V., Miller J., Shih R.N., et al. Serial ten-year follow-up of HLA and MICA antibody production prior to kidney graft failure. Am J Transplant 5 (2005) 2265-2272
18. Mohacsi P., Rieben R., and Nydegger U.E. Immunosuppression in ABO-incompatible transplantation. Transplant Proc 33 (2001) 2223-2224
19. Narayanan K., Jendrisak M.D., Phelan D.L., and Mohanakumar T. HLA class I antibody mediated accommodation of endothelial cells via the activation of PI3K/cAMP dependent PKA pathway. Transpl Immunol 15 (2006) 187-197
20. Oroszlan M., Bieri M., Ligeti N., Farkas A., Koestner S.C., Meier B., et al. Proliferation signal inhibitor-induced decrease of vascular endothelial cadherin expression and increase of endothelial permeability in vitro are prevented by an anti-oxidant. J Heart Lung Transpl 27 (2008) 1311-1318
21. Pierson III R.N., Loyd J.E., Goodwin A., Majors D., Dummer J.S., Mohacsi P., et al. Successful management of an ABO-mismatched lung allograft using antigen-specific immunoadsorption, complement inhibition, and immunomodulatory therapy. Transplantation 74 (2002) 79-84
22. Potter M.D., Barbero S., and Cheresh D.A. Tyrosine phosphorylation of VE-cadherin prevents binding of p120- and beta-catenin and maintains the cellular mesenchymal state. J Biol Chem 280 (2005) 31906-31912
23. Reed E.F., Demetris A.J., Hammond E., Itescu S., Kobashigawa J.A., Reinsmoen N.L., et al. Acute antibody-mediated rejection of cardiac transplants. J Heart Lung Transpl 25 (2006) 153-159
24. Shimizu Y., Geraghty D.E., Koller B.H., Orr H.T., and DeMars R. Transfer and expression of three cloned human non-HLA-A, B, C class I major histocompatibility complex genes in mutant lymphoblastoid cells. Proc Natl Acad Sci U S A 85 (1988) 227-231
25. Stewart S., Winters G.L., Fishbein M.C., Tazelaar H.D., Kobashigawa J., Abrams J., et al. Revision of the 1990 working formulation for the standardization of nomenclature in the diagnosis of heart rejection. J Heart Lung Transpl 24 (2005) 1710-1720
26. Subbotin V., Sun H., Aitouche A., Salam A., Valdivia L.A., Fung J.J., et al. Marked mitigation of transplant vascular sclerosis in FasLgld (CD95L) mutant recipients. The role of alloantibodies in the development of chronic rejection. Transplantation 67 (1999) 1295-1300
27. Terasaki P.I. Humoral theory of transplantation. Am J Transpl 3 (2003) 665-673
28. Terasaki P.I., and Ozawa M. Predictive value of HLA antibodies and serum creatinine in chronic rejection: results of a 2-year prospective trial. Transplantation 80 (2005) 1194-1197
29. Vincent P.A., Xiao K., Buckley K.M., and Kowalczyk A.P. VE-cadherin: adhesion at arm's length. Am J Physiol Cell Physiol 286 (2004) C987-997
30. Yang C.W., Oh E.J., Lee S.B., Moon I.S., Kim D.G., Choi B.S., et al. Detection of donor-specific anti-HLA class I and II antibodies using antibody monitoring system. Transpl Proc 38 (2006) 2803-2806